Evidence map›Paper›PMID 15987389›Full record

ArticleCritical care (London, England)2005

The effect of activated protein C on experimental acute necrotizing pancreatitis.

Levent Yamanel, Levent Yamenel, Mehmet Refik Mas, Bilgin Comert, Ahmet Turan Isik, Sezai Aydin, Nuket Mas, Salih Deveci, Mustafa Ozyurt, Ilker Tasci and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Critical care (London, England), 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Drug Therapy for Acute Pancreatitis.Current treatment options in gastroenterology · 2015
    Article
  11. Article
  12. Effects of trimetazidine in acute pancreatitis induced by L-arginine.Canadian journal of surgery. Journal canadien de chirurgie · 2013
    Article
  13. Article
  14. Review of experimental animal models of biliary acute pancreatitis and recent advances in basic research.HPB : the official journal of the International Hepato Pancreato Biliary Association · 2012
    Review
  15. Article
  16. Article
  17. Use of activated protein C has no avail in the early phase of acute pancreatitis.HPB : the official journal of the International Hepato Pancreato Biliary Association · 2008
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Levent YamanelMedical Intensive Care Unit, Gülhane School of Medicine, Etlik, Ankara, Turkey. lyamanel@gata.edu.tr
Levent Yamenel
Mehmet Refik Mas
Bilgin Comert
Ahmet Turan Isik
Sezai Aydin
Nuket Mas
Salih Deveci
Mustafa Ozyurt
Ilker Tasci
Tahir Unal
Gülhane Askerî Tıp Akademisi · TRAnkara Numune Eğitim ve Araştırma Hastanesi · TRHacettepe University · TRTurkish Armed Forces · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAcute pancreatitis is a local inflammatory process that leads to a systemic inflammatory response in the majority of cases. Bacterial contamination has been estimated to occur in 30-40% of patients with necrotizing pancreatitis. Development of pancreatic necrosis depends mainly on the degree of inflammation and on the microvascular circulation of the pancreatic tissue. Activated protein C (APC) is known to inhibit coagulation and inflammation, and to promote fibrinolysis in patients with severe sepsis. We investigated the effects of APC on histopathology, bacterial translocation, and systemic inflammation in experimental acute necrotizing pancreatitis. MATERIALS AND

methodForty-five male Sprague-Dawley rats were studied. Rats were randomly allocated to three groups. Acute pancreatitis was induced in group II (positive control; n = 15) and group III (treatment; n = 15) rats by retrograde injection of taurocholate into the common biliopancreatic duct. Group I rats (sham; n = 15) received an injection of normal saline into the common biliopancreatic duct to mimic a pressure effect. Group III rats were treated with intravenous APC 6 hours after induction of pancreatitis. Pancreatic tissue and blood samples were obtained from all animals for histopathological examination and assessment of amylase, tumor necrosis factor-alpha, and IL-6 levels in serum. Bacterial translocation to pancreas and mesenteric lymph nodes was measured.

resultsAcute pancreatitis developed in all groups apart from group I (sham), as indicated by microscopic parenchymal necrosis, fat necrosis and abundant turbid peritoneal fluid. Histopathological pancreatitis scores in the APC-treated group were lower than in positive controls (10.31 +/- 0.47 versus 14.00 +/- 0.52; P < 0.001). Bacterial translocation to mesenteric lymph nodes and to pancreas in the APC-treated group was significantly decreased compared with controls (P < 0.02 and P < 0.007, respectively). Serum amylase, tumor necrosis factor-alpha, and IL-6 levels were also significantly decreased in comparison with positive controls (P < 0.001, P < 0.04 and P < 0.001, respectively).

conclusionAPC improved the severity of pancreatic tissue histology, superinfection rates and serum markers of inflammation during the course of acute necrotizing pancreatitis.

Indexed as

AmylasesAnimalsAnticoagulantsBacterial TranslocationInterleukin-6MalePancreatitis, Acute NecrotizingProtein CRatsRats, Sprague-DawleyTaurocholic AcidTumor Necrosis Factor-alphaAmylasesAnticoagulantsInterleukin-6Protein CTaurocholic AcidTumor Necrosis Factor-alpha

Identifiers

PMID15987389
PMCPMC1175873
OpenAlexW1523925180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.